No change to India's two-dose schedule for AstraZeneca vaccine – govt adviser

© Reuters.

NEW DELHI (Reuters) – India will stick to its schedule of giving two doses of AstraZeneca (NASDAQ:)’s vaccine, a senior government adviser said on Tuesday.

“India’s Covishield schedule is of two doses… there is no change and Covaxin is also for two doses,” government advisor V K Paul told reporters at a news conference.

Mixing of vaccines is not a protocol and research is currently being conducted on this, he added.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


READ  Tesla cuts price of Model Y SUV by $3,000, Electrek says


Please enter your comment!
Please enter your name here